Centre Hospitalier de Beauvais Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00389116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier de Beauvais | chg Beauvais

Active Ingredients

Drugs in Phase 4 Trials (1)

Diatrizoate (gastrografin) (1 trial)

Drugs in Other Trials (1)

landiolol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Intestinal Obstruction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2